Collaboration proposal

Dear Shimon,

We have been recently tasked by one of our top pharma partners to seek novel collaboration proposals from academics and SMEs for one of their external partnering programs. The pharma company invites scientists to submit proposals on extension or validation the intravitreal half-life and retinal penetration of biologics. Company is actively looking for (but not limited to) :

– novel biotherapeutics approaches to enable both intravitreal half-life extension and increased retinal penetration of biotherapeutic molecules, and/or

– innovative functional assay models to assess and validate the half-life extension and retinal penetration of biologics.

Based on your proposal, the pharma company will enter into discussion with selected experts, potentially leading to collaboration agreement. Funding will be proposed by the company for the duration of the collaboration. Furthermore, results bear the potential for presentation at research conferences and high impact publications in refereed journals.

Would you be interested in receiving more information about our pharma partner (company name, detailed information about the partnering program, collaboration types, etc.), and how to get in touch with them for a collaboration? It is completely free of charge.

For your information, Inospin has a network of 500+ innovation-driven leading companies (including half of top pharma) with active external R&D programs, which are available on dedicated partnering platforms where academics and SMEs can submit their proposals for collaboration.

Thank you,

Kind regards,

Disclaimer: The information contained in this e-mail is intended only for the individual addressed. If you have received this e-mail by mistake, please notify us immediately by return reply. Be sure to delete this message and all its attachments from your system. Please note that any unauthorized review, copying, disclosure or any other use of this information is strictly prohibited. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, received late or incomplete, or could contain viruses. The sender therefore does not accept any liability for any error or omission in the content of this message, either of which are caused as a result of e-mail transmission. If verification is required, please request a hard-copy version. Thank you.